BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35879108)

  • 1. Dutch GPs' views on prescribing mifepristone and misoprostol: a mixed-methods study.
    Schellekens JE; Houtvast CS; Leusink P; Kleiverda G; Gomperts R
    Br J Gen Pract; 2022 Apr; 72(722):e677-83. PubMed ID: 35879108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and future expectations of mifepristone treatment in early pregnancy failure: a survey among Dutch gynaecologists.
    van den Berg J; Hamel CC; Coppus SF; Snijders MP; Vandenbussche FP
    J Obstet Gynaecol; 2019 Oct; 39(7):1006-1011. PubMed ID: 31215270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mifepristone and misoprostol versus placebo and misoprostol for resolution of miscarriage in women diagnosed with missed miscarriage: the MifeMiso RCT.
    Devall A; Chu J; Beeson L; Hardy P; Cheed V; Sun Y; Roberts T; Ogwulu CO; Williams E; Jones L; Papadopoulos JF; Bender-Atik R; Brewin J; Hinshaw K; Choudhary M; Ahmed A; Naftalin J; Nunes N; Oliver A; Izzat F; Bhatia K; Hassan I; Jeve Y; Hamilton J; Deb S; Bottomley C; Ross J; Watkins L; Underwood M; Cheong Y; Kumar C; Gupta P; Small R; Pringle S; Hodge F; Shahid A; Gallos I; Horne A; Quenby S; Coomarasamy A
    Health Technol Assess; 2021 Nov; 25(68):1-114. PubMed ID: 34821547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for managing miscarriage: a network meta-analysis.
    Ghosh J; Papadopoulou A; Devall AJ; Jeffery HC; Beeson LE; Do V; Price MJ; Tobias A; Tunçalp Ö; Lavelanet A; Gülmezoglu AM; Coomarasamy A; Gallos ID
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD012602. PubMed ID: 34061352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication to Manage Abortion and Miscarriage.
    Beaman J; Prifti C; Schwarz EB; Sobota M
    J Gen Intern Med; 2020 Aug; 35(8):2398-2405. PubMed ID: 32410127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
    Faucher P; Baunot N; Madelenat P
    Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial.
    Chu JJ; Devall AJ; Beeson LE; Hardy P; Cheed V; Sun Y; Roberts TE; Ogwulu CO; Williams E; Jones LL; La Fontaine Papadopoulos JH; Bender-Atik R; Brewin J; Hinshaw K; Choudhary M; Ahmed A; Naftalin J; Nunes N; Oliver A; Izzat F; Bhatia K; Hassan I; Jeve Y; Hamilton J; Deb S; Bottomley C; Ross J; Watkins L; Underwood M; Cheong Y; Kumar CS; Gupta P; Small R; Pringle S; Hodge F; Shahid A; Gallos ID; Horne AW; Quenby S; Coomarasamy A
    Lancet; 2020 Sep; 396(10253):770-778. PubMed ID: 32853559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical termination of pregnancy in general practice in Australia: a descriptive-interpretive qualitative study.
    Dawson AJ; Nicolls R; Bateson D; Doab A; Estoesta J; Brassil A; Sullivan EA
    Reprod Health; 2017 Mar; 14(1):39. PubMed ID: 28288649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective open-label non-inferiority randomised controlled trial comparing letrozole and mifepristone pretreatment in medical management of first trimester missed miscarriage: study protocol.
    Du L; Li RHW; Gemzell-Danielsson K; Du YH; Zhang L; Diao WY; Ho PC
    BMJ Open; 2022 Jan; 12(1):e052192. PubMed ID: 35105623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "I'll just deal with this on my own": a qualitative exploration of experiences with self-managed abortion in the United States.
    Raifman S; Ralph L; Biggs MA; Grossman D
    Reprod Health; 2021 May; 18(1):91. PubMed ID: 33947413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage: an economic evaluation based on the MifeMiso trial.
    Okeke Ogwulu CB; Williams EV; Chu JJ; Devall AJ; Beeson LE; Hardy P; Cheed V; Yongzhong S; Jones LL; La Fontaine Papadopoulos JH; Bender-Atik R; Brewin J; Hinshaw K; Choudhary M; Ahmed A; Naftalin J; Nunes N; Oliver A; Izzat F; Bhatia K; Hassan I; Jeve Y; Hamilton J; Debs S; Bottomley C; Ross J; Watkins L; Underwood M; Cheong Y; Kumar CS; Gupta P; Small R; Pringle S; Hodge FS; Shahid A; Horne AW; Quenby S; Gallos ID; Coomarasamy A; Roberts TE
    BJOG; 2021 Aug; 128(9):1534-1545. PubMed ID: 33969614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two prophylactic medication approaches in addition to a pain control regimen for early medical abortion < 63 days' gestation with mifepristone and misoprostol: study protocol for a randomized, controlled trial.
    Dragoman MV; Grossman D; Kapp N; Huong NM; Habib N; Dung DL; Tamang A
    Reprod Health; 2016 Oct; 13(1):132. PubMed ID: 27733165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Availability of medical abortion medicines in eight countries: a descriptive analysis of key findings and opportunities.
    Grossman A; Prata N; Williams N; Ganatra B; Lavelanet A; Läser L; Asmani C; Elamin H; Ouedraogo L; Rahman MM; Conneh-Duworko MJ; Tehoungue BZ; Chanza H; Phiri H; Bhattarai B; Dhakal NP; Ojo OA; Afolabi K; Kabuteni TJ; Hailu BG; Moses F; Dlamini-Nqeketo S; Zulu T; Rehnström Loi U
    Reprod Health; 2023 Apr; 20(Suppl 1):58. PubMed ID: 37041543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of mifepristone and misoprostol for medical treatment of missed miscarriage in clinical practice-A cohort study.
    Ehrnstén L; Altman D; Ljungblad A; Kopp Kallner H
    Acta Obstet Gynecol Scand; 2020 Apr; 99(4):488-493. PubMed ID: 31784973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical methods for first trimester abortion.
    Zhang J; Zhou K; Shan D; Luo X
    Cochrane Database Syst Rev; 2022 May; 5(5):CD002855. PubMed ID: 35608608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of early pregnancy loss among obstetrician-gynecologists in Massachusetts and barriers to mifepristone use.
    Neill S; Hoe E; Fortin J; Goldberg AB; Janiak E
    Contraception; 2023 Oct; 126():110108. PubMed ID: 37394110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Out-of-clinic and self-managed abortion in Bangladesh: menstrual regulation provider perspectives.
    Crouthamel B; Pearson E; Tilford S; Hurst S; Paul D; Aqtar F; Silverman J; Averbach S
    Reprod Health; 2021 Mar; 18(1):69. PubMed ID: 33766050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-management of first trimester medical termination of pregnancy: a qualitative study of women's experiences.
    Purcell C; Cameron S; Lawton J; Glasier A; Harden J
    BJOG; 2017 Dec; 124(13):2001-2008. PubMed ID: 28421651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Provision of medical abortion by midlevel healthcare providers in Kyrgyzstan: testing an intervention to expand safe abortion services to underserved rural and periurban areas.
    Johnson BR; Maksutova E; Boobekova A; Davletova A; Kazakbaeva C; Kondrateva Y; Landoulsi S; Lazdane G; Monolbaev K; Seuc Jo AH
    Contraception; 2018 Feb; 97(2):160-166. PubMed ID: 29133110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial.
    Bracken H; Dabash R; Tsertsvadze G; Posohova S; Shah M; Hajri S; Mundle S; Chelli H; Zeramdini D; Tsereteli T; Platais I; Winikoff B
    Contraception; 2014 Mar; 89(3):181-6. PubMed ID: 24332431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.